This risk model provides a consistent way of assessing and recording the details of any proposed use of cloud services, producing a risk class indication.
This guidance presents a framework for assessing and managing risk around the use of public cloud technologies in the health and social care sectors in England. This framework is intended to be treated as guidance and is recommended to be
This document provides advice and guidance about the safeguards that should be put in place to enable health and social care organisations to safely locate health and care data, including patient information, in the public cloud.
This guidance provides a one page overview to support you in your role as data controller, ensuring that all uses of public cloud are well-executed: known, safe, secure and effective.
Guidance from NHS Digital setting clear expectations for health and care organisations who want to use cloud services or data offshoring to store patient information. The guidance ensures that organisations know how to use these solutions safely and securely, especially in
This document sets out what all health and care organisations will be expected to do to demonstrate that they are putting into practice the 10 data security standards recommended by the National Data Guardian.
One year on from the launch of the Developing People- Improving Care, we highlight how leaders across health and social care have implemented the framework. This involves ensuring systems of compassion, inclusion and improvement, are at the core of the health
Guide from NHS Providers and Hempsons identifying seven key steps STPs and their partner organisations should consider to support the evolution to accountable care. Key issues to consider are: Phasing Partners Governance Contracting Funding Organisational Form Enablers
Produced by Care Quality Commission, NHS England and NHS Clinical Commissioners, aims to help staff working in CQC, NHS England and CCGs reduce duplication in the regulation and oversight of general practice.
An Accountable Care Organisations (ACO) is a model of healthcare organisation where a provider, or group of providers, takes responsibility for the healthcare provision of an entire population. There is no fixed definition of an ACO, but the organisation usually receives an annual,
Leading Large Scale Change: a practical guide has been produced by the NHS England Sustainable Improvement Team and the Horizons Team, NHS England, to help all those involved in seeking to achieve transformational change in complex health and care environments.
The NHS Improvement remit letter for 2017 to 2018 sets out the strategic objectives for the organisation around: NHS budget delivery of safe, high quality care NHS operational performance alignment with the Five Year Forward View NHS leadership The letter
This document provides practical guidance to Local Maternity Systems on how to improve their services so that women experience continuity in the clinicians providing their maternity care.
House of Commons Committee on Exiting the European Union assessment of the impact of Brexit on the Life Science Sector including Medical Devices and Pharmaceuticals.
House of Commons Committee on Exiting the European Union assessment of the impact of Brexit on the Medical Services and Social Care Sector.
General Medical Council report that analyses data on the medical workforce across the UK. It identifies a raft of challenges facing the medical profession today against a backdrop of an increasing and older population, and highlights four priorities for the
NHS Employers factsheet developed with Capsticks, identifying the key changes in data protection legislation that will affect the way that employers in NHS organisations carry out tasks involving personal data, particularly around employment checks and recruitment processes.
The charts shown in this document give an overview of the key strategic EPRR guidance documents currently published. For published documents, website links are embedded in the charts.
The National Data Guardian (NDG) has published a report looking back over the three years since the creation of the role and describing future priorities. It sets out a clear case for the independent advice and challenge the role provides to ensure
Evidence-based recommendations on atezolizumab (Tecentriq) for locally advanced or metastatic urothelial carcinoma in adults. This guidance only includes recommendations for untreated urothelial carcinoma when cisplatin-based chemotherapy is unsuitable. NICE are developing separate guidance for urothelial carcinoma that has progressed after platinum-containing chemotherapy.